FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 340:956-958 March 25, 1999 Number 12 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Bonenkamp, J.J. PubMed Citation

In this issue of the Journal, Bonenkamp et al.¹ report the results of a Dutch trial in which 711 patients with gastric cancer were randomly assigned to gastrectomy with either a limited (D1) lymph-node dissection (380 patients) or an extended (D2) lymph-node dissection (331 patients). The concept of extended lymph-node dissection was developed five decades ago, and there are claims based on historical data that extended surgical resection, especially extended lymph-node dissection, improves the outcome in gastric cancer.² The procedure has lost favor, however, because of excessive morbidity and mortality. Nevertheless, it has continued to be the standard approach used . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Pacelli, F., Rosa, F., Doglietto, G. B. (2009). Total Gastrectomy--Reply. Arch Surg 144: 290-290 [Full Text]  
• Bilimoria, K. Y., Talamonti, M. S., Wayne, J. D., Tomlinson, J. S., Stewart, A. K., Winchester, D. P., Ko, C. Y., Bentrem, D. J. (2008). Effect of Hospital Type and Volume on Lymph Node Evaluation for Gastric and Pancreatic Cancer. Arch Surg 143: 671-678 [Abstract] [Full Text]  
• Nitti, D., Wils, J., Dos Santos, J. G., Fountzilas, G., Conte, P. F., Sava, C., Tres, A., Coombes, R. C., Crivellari, D., Marchet, A., Sanchez, E., Bliss, J. M., Homewood, J., Couvreur, M. L., Hall, E., Baron, B., Woods, E., Emson, M., Van Cutsem, E., Lise, M. (2006). Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG. Ann Oncol 17: 262-269 [Abstract] [Full Text]  
• Schwarz, R. E., Smith, D. D. (2005). Extended Lymph Node Dissection for Gastric Cancer: Who May Benefit? Final Results of the Randomized Dutch Gastric Cancer Group Trial. JCO 23: 5404-5405 [Full Text]  
• Schwarz, R. E., Kelsen, D. P. (2001). Postoperative Adjuvant Chemoradiation Therapy for Patients With Resected Gastric Cancer: Intergroup 116. JCO 19: 1879-1880 [Full Text]  
• Doglietto, G. B., Pacelli, F., Caprino, P., Bossola, M., Stasi, C. D. (2000). Pancreas-Preserving Total Gastrectomy for Gastric Cancer. Arch Surg 135: 89-92 [Abstract] [Full Text]